Literature DB >> 403555

Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space.

F W Van der Poel, H M Van Praag, J Korf.   

Abstract

The location of probenecid-sensitive elimination mechanisms of monoamine metabolites from the cerebrospinal fluid of the cat was determined with ventriculo-cisternal or ventriculo-lumbar perfusion techniques. These techniques were described in detail. Levels of endogenous homovanillic acid and 5-hydroxyindoleacetic acid were assayed in the perfusate. Probenecid administration induced the most marked increase of the levels of the monoamine metabolites in the ventriculo-lumbar perfusates. It was concluded that probenecid blocked the transport of both metabolites from the spinal subarachnoid space.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403555     DOI: 10.1007/bf00426597

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Determination of nanogram amounts of homovanillic acid in the central nervous system with a rapid semiautomated fluorometric method.

Authors:  B H Westerink; J Korf
Journal:  Biochem Med       Date:  1975-02

2.  On the occurrence and distribution of 5-hydroxyindoleacetic acid in brain.

Authors:  B E ROOS
Journal:  Life Sci (1962)       Date:  1962-01

3.  The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus.

Authors:  S S Sampath; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

Review 4.  Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.

Authors:  E Garelis; S N Young; S Lal; T L Sourkes
Journal:  Brain Res       Date:  1974-10-11       Impact factor: 3.252

5.  5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.

Authors:  S N Young; S Lal; J B Martin; R M Ford; T L Sourkes
Journal:  Psychiatr Neurol Neurochir       Date:  1973 Nov-Dec

6.  Homovanillic acid and 3-methoxy-4-hydroxyphenylethyleneglycol production by the monkey spinal cord.

Authors:  J A Kessler; E K Gordon; J L Reid; I J Kopin
Journal:  J Neurochem       Date:  1976-06       Impact factor: 5.372

7.  Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.

Authors:  M Bulat; B Zivković
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

8.  Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors:  H C Guldberg; G W Ashcroft; T B Crawford
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

9.  Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.

Authors:  N H Neef; T N Tozer; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1967-11       Impact factor: 4.030

10.  The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog.

Authors:  G W Ashcroft; R C Dow; A T Moir
Journal:  J Physiol       Date:  1968-12       Impact factor: 5.182

View more
  6 in total

1.  Probenecid-induced increase of 5-hydroxytryptamine synthesis in rat brain, as measured by formation of 5-hydroxytryptophan.

Authors:  M van Wijk; J B Sebens; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

2.  Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.

Authors:  C M Banki
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

3.  Accumulation of 3H-(-)noradrenaline in the rabbit aorta not related to uptake1 and uptake2, but sensitive to 3,4-dihydroxy-2-methylpropiophenone (U-0521) and oxytetracycline.

Authors:  M Henseling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

4.  Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD.

Authors:  Eleonore Rydén; Christian Johansson; Kaj Blennow; Mikael Landén
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

5.  Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid.

Authors:  S N Young; B A Davis; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

6.  CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.

Authors:  J Malm; B Kristensen; J Ekstedt; P Wester
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.